SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-22-242024
Filing Date
2022-09-09
Accepted
2022-09-09 16:40:34
Documents
10

Document Format Files

Seq Description Document Type Size
1 424B3 d392856d424b3.htm 424B3 2775288
2 GRAPHIC g392856g04a52.jpg GRAPHIC 37674
3 GRAPHIC g392856g11u28.jpg GRAPHIC 138313
4 GRAPHIC g392856g13k91.jpg GRAPHIC 94826
5 GRAPHIC g392856g14q82.jpg GRAPHIC 636657
6 GRAPHIC g392856g15s01.jpg GRAPHIC 91529
7 GRAPHIC g392856g18b81.jpg GRAPHIC 76485
8 GRAPHIC g392856g18s02.jpg GRAPHIC 108861
9 GRAPHIC g392856g20s03.jpg GRAPHIC 81463
10 GRAPHIC g392856g22s04.jpg GRAPHIC 108861
  Complete submission text file 0001193125-22-242024.txt   4625845
Mailing Address 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070
Business Address 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070 650.931.6236
Apexigen, Inc. (Filer) CIK: 0001814140 (see all company filings)

IRS No.: 851260244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-266847 | Film No.: 221236608
SIC: 2834 Pharmaceutical Preparations